Will new AR inhibitors reshape the prostate cancer landscape?

Tombal, Bertrand

doi:10.1016/S1470-2045(14)70292-X

Will new AR inhibitors reshape the prostate cancer landscape?

Tombal, Bertrand

(2014) The Lancet Oncology — Vol. 15, n° 9, p. 912-913 (2014)

Files

Tombal-2014-WillnewARinhibitorsreshape.pdf

Restricted Access
Adobe PDF
189.24 KB

Request a copy

Details

Authors

Tombal, BertrandUCLouvain
Author

Affiliations

UCLouvainSSS/IREC/CHEX - Pôle de chirgurgie expérimentale et transplantation
UCLouvain(SLuc) Service d'urologie

Citations

APA
Chicago
FWB

Tombal, B. (2014). Will new AR inhibitors reshape the prostate cancer landscape? The Lancet Oncology, 15(9), 912-913. https://doi.org/10.1016/S1470-2045(14)70292-X (Original work published 2014)